Pharmacology and structure-activity relationships of alpha 2-adrenoceptor antagonists

Review

R D Clark et al. Prog Med Chem. 1986.

. 1986:23:1-39.

doi: 10.1016/s0079-6468(08)70339-4.

No abstract available

Similar articles

Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.
Ruffolo RR Jr, Bondinell W, Hieble JP. Ruffolo RR Jr, et al. J Med Chem. 1995 Sep 15;38(19):3681-716. doi: 10.1021/jm00019a001. J Med Chem. 1995. PMID: 7562902 Review. No abstract available.
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Timmermans PB, de Jonge A, Thoolen MJ, Wilffert B, Batink H, van Zwieten PA. Timmermans PB, et al. J Med Chem. 1984 Apr;27(4):495-503. doi: 10.1021/jm00370a011. J Med Chem. 1984. PMID: 6142954
Alpha adrenoceptor pharmacology.
Tranquilli W, Thurmon JC. Tranquilli W, et al. J Am Vet Med Assoc. 1984 Jun 1;184(11):1400-2. J Am Vet Med Assoc. 1984. PMID: 6145696 No abstract available.
Pharmacological options in the treatment of benign prostatic hyperplasia.
Kenny B, Ballard S, Blagg J, Fox D. Kenny B, et al. J Med Chem. 1997 Apr 25;40(9):1293-315. doi: 10.1021/jm960697s. J Med Chem. 1997. PMID: 9135028 Review. No abstract available.
Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes.
Ruffolo RR Jr, Nichols AJ, Stadel JM, Hieble JP. Ruffolo RR Jr, et al. Annu Rev Pharmacol Toxicol. 1993;33:243-79. doi: 10.1146/annurev.pa.33.040193.001331. Annu Rev Pharmacol Toxicol. 1993. PMID: 8098595 Review. No abstract available.

Variable selection and specification of robust QSAR models from multicollinear data: arylpiperazinyl derivatives with affinity and selectivity for alpha2-adrenoceptors.
Salt DW, Maccari L, Botta M, Ford MG. Salt DW, et al. J Comput Aided Mol Des. 2004 Jul-Sep;18(7-9):495-509. doi: 10.1007/s10822-004-5203-7. J Comput Aided Mol Des. 2004. PMID: 15729849
The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM, MacKinnon AC, Redfern WS, Hicks PE, Kilpatrick AT, Small C, Ramcharan M, Clague RU, Clark RD, MacFarlane CB, et al. Brown CM, et al. Br J Pharmacol. 1993 Feb;108(2):516-25. doi: 10.1111/j.1476-5381.1993.tb12834.x. Br J Pharmacol. 1993. PMID: 8095420 Free PMC article.